72 related articles for article (PubMed ID: 565049)
21. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
Guo F; Liu J; Wang C; Liu N; Lu P
Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
[TBL] [Abstract][Full Text] [Related]
22. Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization.
Nakayama-Hamada M; Suzuki A; Furukawa H; Yamada R; Yamamoto K
J Biochem; 2008 Sep; 144(3):393-8. PubMed ID: 18583356
[TBL] [Abstract][Full Text] [Related]
23. [Presence of an active fibrinogen--heparin complex in the total blood plasma fraction of plasma fibrinogen degradation products].
Kudriashov BA; Liapina LA; Ul'ianov AM
Biokhimiia; 1977 Mar; 42(3):451-9. PubMed ID: 861306
[TBL] [Abstract][Full Text] [Related]
24. Proceedings: Gamma'-dimer antibody and its specificity against fibrinogen, FR-a and carboxymethylated chains from fibrinogen and cross-linked fibrin.
Clausen NT; Gormsen J
Thromb Diath Haemorrh; 1975 Sep; 34(1):326. PubMed ID: 1188740
[No Abstract] [Full Text] [Related]
25. [In vivo behavior of soluble fibrin monomer after cleavage of fibrinopeptide A].
Müller-Berghaus G; Mahn I
Verh Dtsch Ges Inn Med; 1978; (84):1351-3. PubMed ID: 741964
[No Abstract] [Full Text] [Related]
26. Measurement of autoantibodies against fibrinogen and fibrin degradation products by enzyme-linked immunoassay.
Whitaker AN; McFarlane JR; Rowe EA; Lee K; Masci PP
Thromb Haemost; 1985 Feb; 53(1):80-5. PubMed ID: 3992524
[TBL] [Abstract][Full Text] [Related]
27. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
28. Possible role of fibrinogen in the aggregation of white blood cells.
Berliner S; Fuchs J; Seligsohn U; Kariv N; Hazaz B; Rotenberg Z; Weinberger I; Agmon J; Pinkhas J; Aronson M
Thromb Haemost; 1987 Aug; 58(2):749-52. PubMed ID: 3672427
[TBL] [Abstract][Full Text] [Related]
29. The role of antimicrobial peptides in cardiovascular physiology and disease.
Li Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):363-7. PubMed ID: 19818331
[TBL] [Abstract][Full Text] [Related]
30. [Hemostatic changes in late pregnancy toxicosis].
Kholevich B
Akush Ginekol (Sofiia); 1984; 23(5):452-5. PubMed ID: 6393786
[No Abstract] [Full Text] [Related]
31. [Biological activity of fibrinogen derivatives].
Kopeć M
Pol Arch Med Wewn; 1978 Jan; 59(1):1-7. PubMed ID: 148641
[No Abstract] [Full Text] [Related]
32. [A group of monoclonal antibodies against human fibrinogen and its fragments].
Wu XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):288-90. PubMed ID: 2976318
[No Abstract] [Full Text] [Related]
33. [Structure, metabolism and pathophysiological importance of fibrinogen].
Lepsanovic LJ
Med Pregl; 1976; 29(5-6):287-94. PubMed ID: 940540
[No Abstract] [Full Text] [Related]
34. [Determination of the fibrinogen/fibrin antigen content in the blood plasma and serum by radial immunodiffusion].
Iakunin GA; Smolianitskiĭ AIa; Kurguzova OP; Grabskiĭ MA
Lab Delo; 1982; (7):408-10. PubMed ID: 6181303
[No Abstract] [Full Text] [Related]
35. Leukotrienes in cardiovascular and pulmonary function. 26th annual A.N. Richards Symposium. Bala Cynwyd, Pennsylvania, May 6-7, 1985.
Prog Clin Biol Res; 1985; 199():1-270. PubMed ID: 4070314
[No Abstract] [Full Text] [Related]
36. Altered immunoelectrophoretic profiles of fibrinogen in full-term newborns.
Kordich L; Bergonzelli G; Lago O; Sassetti B; Porterie P
Thromb Res; 1986 Dec; 44(5):695-700. PubMed ID: 3810568
[No Abstract] [Full Text] [Related]
37. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
Brenner B; Francis CW; Marder VJ
J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
[TBL] [Abstract][Full Text] [Related]
38. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
Ivanov EP; Tsvirko DG
Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
[TBL] [Abstract][Full Text] [Related]
39. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
Widström O; Kockum C; Nilsson BS
Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
[TBL] [Abstract][Full Text] [Related]
40. Determination of fibrinogen degradation products by immuno-enzymological assay.
Soria J; Soria C
Thromb Res; 1978 Jun; 12(6):1025-35. PubMed ID: 358481
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
